A comprehensive temporal proteome and phosphoproteome dataset of Y1 adrenocortical cells under FGF2 stimulation and SOS inhibition

Inside the microscopic world of a cell, life and death are often decided by a rapid exchange of chemical messages. Imagine a cell as a small factory that must constantly decide whether to grow and divide or to shut down and die. In many cancer cells, the machinery that controls this decision is stuck in the "grow" position, driven by a specific protein called KRAS. This protein acts like a switch that, when flipped on, tells the cell to multiply. Scientists have long known that in a specific type of mouse cancer cell called Y1, this switch is turned on by a helper protein named SOS. However, recent observations suggested that the story was more complicated than a single helper turning a single switch. In these cells, a different growth signal, called FGF2, does something unexpected: instead of making the cells grow, it triggers a toxic stress that leads to their death. This paradoxical reaction, where a growth signal causes cell death, hinted that the internal wiring of the cell was more complex than previously understood, involving other hidden helpers and regulators that scientists had not yet fully mapped.

To uncover the hidden mechanics of this life-and-death switch, researchers Fabio Montoni and his team set out to watch the cell's internal machinery in real time. They focused on the Y1 mouse adrenocortical tumor cell line, a classic model for studying how cells respond to stress and growth signals. The team wanted to see exactly how the cell's proteins changed when it was bombarded with the FGF2 signal, and how those changes were altered when they blocked the known helper protein, SOS, using a specific inhibitor drug. They did not just look at a single moment; instead, they captured a high-speed movie of the cell's response, taking snapshots at intervals ranging from five seconds to thirty minutes after the signal was introduced. By comparing cells that received the signal alone against those that also had the SOS helper blocked, and by testing them with and without a standard growth serum, they created a detailed map of the cell's reaction.

The researchers used advanced mass spectrometry, a technique that acts like a highly sensitive scale capable of weighing and identifying thousands of different protein molecules at once. They measured two specific things: the total amount of proteins present in the cell, which represents the cell's structural inventory, and the phosphorylation of those proteins. Phosphorylation is a chemical tag that cells attach to proteins to instantly turn them on or off, acting as a rapid control mechanism for cellular activity. In their experiment, the team analyzed nearly 9,000 different protein groups and identified over 14,000 specific sites where these chemical tags were attached. This massive dataset allowed them to see not just what proteins were present, but exactly how their activity was being modulated in the split second after the signal arrived.

The results revealed a striking difference between the cell's structural inventory and its activity controls. Over the thirty-minute period, the total number of proteins in the cell remained remarkably stable, changing very little regardless of the treatment. This stability suggests that the cell did not need to build new parts or destroy old ones to react to the stress; instead, it simply rewired its existing machinery. However, the activity tags told a different story. The researchers found that more than 10,000 of the identified chemical tags changed significantly in abundance. This massive shift in activity occurred even though the underlying proteins stayed the same, confirming that the cell's response was driven by rapid reprogramming of its existing components rather than the production of new ones.

When the researchers looked closely at how these changes unfolded over time, they saw a clear pattern. The earliest moments of the experiment, lasting only a few seconds, showed very little difference between the treated cells and the control cells. The major changes only became visible after the signal had been present for ten to thirty minutes. This delay suggests that the cell requires a sustained period of stimulation before it commits to its final response. Furthermore, when the researchers blocked the SOS helper protein, the pattern of changes shifted, revealing that SOS is not the only player in the game. The data supports the finding that SOS is not solely responsible for KRAS activation in these cells and that another helper, the GEF RASGRP4, is essential for sustaining the tumor phenotype. This indicates a complex regulatory landscape where multiple pathways work together to keep the cancer cells active.

The study also identified specific proteins that responded strongly to the combination of the growth signal and the SOS inhibitor. Among these were proteins known to be involved in cancer progression and cell signaling, such as JUNB and SERPINE1. These molecules are part of the MAPK signaling pathway, a major communication route that controls cell growth and survival. By mapping which proteins changed and when, the team provided a comprehensive view of how the cell navigates the decision between life and death. The dataset they generated is now available for other scientists to use, offering a rich resource for building computer models that can simulate these cellular decisions. This work does not just confirm that the SOS protein is important; it explicitly shows that blocking it does not stop the cell's activity entirely, pointing to other essential helpers that keep the cancer phenotype alive. The findings provide a clearer, more detailed picture of the molecular tug-of-war that determines whether a cancer cell survives or succumbs to stress.